AVEO

AVEO Pharmaceuticals, Inc. News Headlines

$3.01
*  
0.20
  negative  
7.12%
Get AVEO Alerts
*Delayed - data as of May 17, 2013 
Exchange: NASDAQ
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Should Aveo Run Second Study of Kidney Cancer Drug, FDA Asks
4/30/2013 11:07:00 AM - TheStreet

Pre-Market Most Active for Apr 30, 2013 : SIRI, MTU, SMFG, PFE, DCM, NTT, STM, NUAN, VOD, ANAD, AVEO, BBRY
4/30/2013 8:39:54 AM - NASDAQ.com News

Prepping for Aveo, Delcath FDA Panels
4/29/2013 2:06:00 PM - TheStreet

Cramer's Mad Money - 16 Things To Watch In The Week Ahead (4/26/13)
4/28/2013 5:07:00 AM - Seeking Alpha

Biotech Stock Mailbag: ASCO, Sarepta, Cel-Sci and Hate Mail!
4/26/2013 8:15:00 AM - TheStreet

Aveo's Kidney Cancer Drug Won't Get FDA Panel OK
4/25/2013 10:10:00 AM - TheStreet

Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval
4/24/2013 10:08:00 AM - Seeking Alpha

Quickly Approaching Biopharma Catalyst Events
4/24/2013 8:30:00 AM - Seeking Alpha

Aveo's Upcoming AdCom - Tivozanib's Safety Will Lead The Way Towards Approval
4/22/2013 5:05:00 PM - Seeking Alpha

Thursday's BioPharma Trade Movers
4/18/2013 9:28:00 AM - Seeking Alpha

AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential
4/16/2013 7:55:00 AM - Seeking Alpha

Why We Expect The FDA To Approve Aveo's Tivozanib
4/16/2013 2:18:00 AM - Seeking Alpha

2 Oncology Biotechs For The Future
4/14/2013 3:44:00 PM - Seeking Alpha

Syros Pharma Announces $30 Mln Series A Financing
4/11/2013 1:13:00 PM - RTT News

3 Healthcare Stocks Waiting For The FDA's Approval
4/5/2013 3:58:00 PM - Seeking Alpha

3 Small Cap Biopharmas Primed To Move Much Higher Now
3/27/2013 8:50:00 AM - Seeking Alpha

2 Cancer Biotechs With Upcoming FDA Approval Decisions In 2013
3/22/2013 7:35:00 PM - Seeking Alpha

Why AVEO Pharmaceuticals' Tivozanib Will Be Approved For The Treatment Of Advanced Renal Cell Carcinoma
3/20/2013 1:11:29 PM - SeekingAlpha

Is AVEO's Tivozanib Any Better Than Placebo For The Treatment Of Renal Cell Carcinoma?
3/14/2013 10:16:00 AM - Seeking Alpha

Panel to Review AVEO/ALPMY's Drug - Analyst Blog
3/6/2013 6:55:03 PM - Zacks.com

ZGNX Soars, ATRS Gets Date With FDA, AVEO, TTNP To Face Panel, CRDC Takes Heart
2/27/2013 10:26:00 PM - RTT News

AVEO Pharma To Present At RBC Capital Markets Conference; Webcast At 2:00 PM ET
2/27/2013 1:02:00 PM - RTT News

AVEO Oncology: FDA Panel To Review Tivozanib For Treatment Of Advanced RCC
2/27/2013 6:40:00 AM - RTT News

A Review Of Seth Klarman's Baupost Group's Q4 U.S. Equity Changes
2/18/2013 1:58:00 PM - Seeking Alpha

Tracking Seth Klarman's Baupost Group Holdings - Q4 2012 Update
2/14/2013 3:58:00 AM - Seeking Alpha